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Abstract
Background Previous studies have demonstrated a rela-
tionship between central adiposity and cognitive function.
However, only some of these studies have adjusted for
cardiovascular risk factors and cardiovascular disease, and
none have also adjusted for physical activity level.
Purpose The purpose of the study was to examine the
association between anthropometric measures of central
adiposity (waist circumference and waist/hip ratio) and
cognitive functioning with adjustment for cardiovascular
disease risk factors and physical activity.
Methods Participants were 917 stroke- and dementia-free
community-dwelling adults (59% women) in the Maine–
Syracuse Study. The design was cross-sectional. Outcome
measures included tests from the Wechsler Adult Intelligence
Scale, the Halstead-Reitan Neuropsychological Battery, the
Wechsler Memory Scale Revised, and the Mini-Mental State
Examination.
Results Waist circumference and waist/hip ratio were
inversely related to multiple cognitive domains with
adjustment for age, education, gender, and number of prior
exams. For example, a 20-cm increment in waist circum-
ference was associated with a 0.14 SD decrement in the
Global Composite score. These relations were attenuated
with adjustment for cardiovascular disease risk factors.
However, with further adjustment for physical activity
level, only waist circumference remained significantly
associated with performance on the Similarities test.
Conclusions Waist circumference and waist/hip ratio are
inversely related to cognitive function. Measures of central
adiposity predict cognitive function independently of
associated cardiovascular risk factors and events; however,
the association between central adiposity and cognitive
function is attenuated, to a large extent, by adjustment for
physical activity level. Physical activity is an important
covariate in studies relating measures of central adiposity to
cognition.
Keywords Waist circumference .Waist/hip ratio .
Adiposity . Cognitive function . Physical activity .
Cardiovascular risk
Introduction
Obesity is a risk factor for cardiovascular disease (CVD),
all-cause mortality [1], and morbidity [2, 3] and plays a
central role in the metabolic syndrome [4]. In previous
studies, a negative relationship between body mass index
(BMI) and cognitive function [5–7] has been reported, but a
measure of central adiposity was not employed. Central
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adiposity measures (i.e., waist circumference (WC) or
waist/hip ratio (WHR)) provide more information than
BMI concerning the distribution of body fat. Adipose tissue
accumulated in the hip region may have a protective effect
regarding cardiovascular disease and risk factors [8], and
waist circumference has been shown to be a better predictor
of all-cause mortality [9, 10], CVD mortality [11], and risk
of CVD events [12] than BMI.
Recently, studies have been undertaken to relate mea-
sures of central adiposity to cognitive performance. An
interactive effect of central adiposity and high blood
pressure has been reported [13, 14], such that an inverse
relationship between waist circumference or waist/hip ratio
and cognitive function was observed in hypertensive, but
not normotensive, individuals. Wolf et al. [14] adjusted
only for age, education, and gender, whereas Waldstein and
Katzel [13] adjusted for age, education, gender, multiple
demographic and CVD risk factors, and components of the
metabolic syndrome.
Physical activity level and cardiorespiratory fitness have
received relatively little attention as possible confounders
of the relation between central adiposity measures and
cognitive performance. These variables are important
predictors of cognitive function [15–17]. Indeed, improved
cognitive test performance has been observed following
exercise training [18]. Physical activity levels are also
associated with decreased risk of mortality [19] and chronic
disease, including diabetes mellitus [20]. Thus, in the
present study, in addition to adjusting relations between
adiposity and cognitive performance for CVD risk factors
and events, we adjusted for physical activity level.
Our hypotheses were as follows: (1) measures of central
adiposity, waist circumference and waist/hip ratio, will be
inversely related to multiple domains of cognitive function;
(2) the association between measures of central adiposity
and cognitive performance will be sustained, though
modestly attenuated, when adjusted for CVD factors and
CVD events; (3) positive associations between physical
activity level and cognitive performance will be observed;
(4) statistically adjusting for physical activity will result in a
major attenuation of relations between central adiposity and
cognitive performance.
Method
Participants
The sample was provided by the Maine–Syracuse Longi-
tudinal Study [MSLS; 21, 22]. This community-based
study, initiated in 1975, involves a time-lagged sample of
five cohorts defined by time of entry into the study (1975–
2000). The MSLS provides data on cognitive functioning
and blood pressure, CVD, CVD risk factors (CVD-RF),
stroke, and prescription drugs, based on medical examina-
tion, an in-depth diagnostic interview, and hospital and
physician records. The data from the current study are taken
from the sixth study examination (2001–2006), as indices
of central adiposity and some important CVD risk factors
were first obtained at this exam.
Beginning with a sample size of 965, participants were
excluded for the following reasons: stroke (n=33), dementia
(n=8), active dialysis treatment (n=5), chronic alcohol
abuse (n=1), and not fluent in the English language (n=1).
The clinical diagnosis of dementia was determined by a
panel consisting of one neurologist-geriatrician and three
neuropsychologists using the National Institute of Neurolog-
ical and Communicative Diseases and Stroke–Alzheimer’s
Disease and Related Disorders Association criteria and
cognition and medical interview data from the Maine–
Syracuse Study [23]. Prevalent stroke, defined as a focal
neurological deficit of acute onset persisting more than 24 h,
was based on self-report and record review (with permission)
and confirmed by hospitalization, treatment for stroke, or
both.
We certify that all applicable institutional and govern-
mental regulations concerning the ethical use of human
volunteers were followed during this research. The Univer-
sity of Maine Institutional Review Board approved the
investigation and informed consent for data collection, and
medical record review was obtained for all participants.
Procedure
Participants completed questionnaires, including the Center
for Epidemiologic Studies depression scale [CES-D; 24]
and the Nurses’ Health Study Activity Questionnaire [17],
within a week prior to the study. They were admitted to the
study center following a fast from midnight. A blood
sample was drawn by a licensed phlebotomist, and a light
breakfast, including decaffeinated coffee or tea, was served
and followed by a physical examination, including a
detailed medical history and neuropsychological testing.
Waist circumference and hip circumference (in centimeters)
were both measured using a non-extendable measuring
tape. Waist circumference was measured at the level of the
iliac crest, and hip circumference was measured at the
largest extension of the buttocks. All measurements were
taken with the subject wearing light clothing.
Neuropsychological Battery
The tests included in the neuropsychological battery, with a
brief description of what each test measures and references
to the origins of the tests and details of test administration,
may be found in Table 1. The battery, designed to measure
342 ann. behav. med. (2008) 35:341–350
a wide range of cognitive abilities [25], has been employed
in studies relating hypertension and other cardiovascular
risk factors to cognitive performance [21, 22].
We employed the Mini-Mental State Examination
[MMSE; 26] and the Maine–Syracuse neuropsychological
test battery [21, 22, 27–29], which included the Similarities
test from the Wechsler Adult Intelligence Scale [WAIS; 30]
and four composite scores resulting from a previous factor
analysis [21] which identified four relatively independent
cognitive domains: Visual–Spatial Memory and Organiza-
tion, Scanning and Tracking, Verbal Episodic Memory, and
Working Memory. Each composite score was constructed
by summing standard scores for the Hopkins Verbal
Learning Test [31], the Hooper Visual Organization Test
[32, 33], the Controlled Oral Word Associations Test [34],
and multiple individual tests taken from the Halstead–
Reitan Neuropsychological Test Battery [35], the Wechsler
Memory Scale-Revised [36], the original WAIS [30], and
the WAIS III [37].
Test scores were transformed to z-scores. This linear
transformation results in a mean of zero and a standard
deviation (SD) of 1.00 for each test and represents an
expression of regression coefficients for the cognitive
measures in terms of SD units. Factor analytic methods
and tests making up the composites are fully described in a
recent paper [28]. These previously identified composites
were confirmed in the present study via replication of the
factor analysis. The Similarities subtest from the WAIS, a
measure of abstract reasoning [25, 30], loaded on mul-
tiple factors and was treated as a separate measure. In
addition to composite scores based on factor analysis, a
Global Composite score was calculated by averaging the
z-scores for all individual tests (excluding the MMSE).
The Global Composite and MMSE were considered
separate measures of global performance. All the tests
used in the composite scores are widely used in research
and clinical practice and have been described elsewhere in
detail [25, 26, 30, 34–37].
Table 1 Descriptions of the cognitive tests with factor loadings from the factor analysis confirmed in this study
Test composite/tests included in the composite Latent cognitive variable tested Reference
Global composite (z score) Global composite of cognitive performance
Verbal memory
Logical memory-immediate recalla Immediate memory, verbal 36
Logical memory-delayed recalla Delayed memory, verbal 36
Hopkins verbal learning test Verbal learning and memory 31
Visual–spatial organization
Visual reproductions-immediate recalla Immediate recall, visual memory, and visual–spatial
problem solving
36
Visual reproductions-delayed recalla Delayed recall, visual memory and visual–spatial
problem solving
36
Matrix reasoningb Abstract reasoning and pattern recognition 37
Block designc Visual–spatial perception, organization and construction 30
Object assemblyc Speed of visual–spatial organization 30
Hooper visual organization test Visual–spatial organization; some demands on
executive function
32, 33
Scanning and tracking
Trail making Ad Visual scanning and tracking 35
Trail making Bd Complex visual scanning, tracking and executive function 35
Digit symbol substitutionc Psychomotor performance 30
Symbol searchb Visual processing speed 37
Working memory
Digit span forwardc Attention and concentration 30
Digit span backwardc Attention, concentration, and working memory 30
Letter–number sequenceb Working memory 37
Controlled oral word associations Verbal fluency and executive functioning 34
Similaritiesc Abstract reasoning 30
Mini-Mental State Examination (MMSE)e Global cognitive screening 26
a Origin WMS-R
bOrigin WAIS III
c Origin WAIS
dOrigin Halstead-Reitan NP Test Battery
e Excluded from the factor analysis
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Independent Variables and Covariates
The independent variables were WC (in centimeters) and
WHR. Covariates employed in the regression models
(described below) were age (years), education (years),
gender, number of prior examinations, smoking (cigarettes
per week), the ratio of triglycerides (mmol/l) to high density
lipoprotein cholesterol (mmol/l; TG/HDL-C), prevalent
CVD, high sensitivity C-reactive protein (CRP; mg/l),
systolic blood pressure (SBP; mm Hg), depressed mood,
glucose (mg/dl), and physical activity (PA; metabolic
equivalent task (MET)-hours per week).
Education level was obtained through self-report and
ranged from 4 to 20 years. Gender was coded as 0 for men
and 1 for women. Although the current study is cross-
sectional, as noted previously, participants were recruited
into the parent (longitudinal) study at various waves.
Consequently, the number of prior exams for each subject
(range from 1 to 5) was used as a covariate scored from 1 to
5. Smoking was measured by self-reported number of
cigarettes smoked per week. Glucose, TG and HDL-C were
assessed from serum using standard colorimetric methods at
a commercial laboratory. Analyses (not presented) were
also performed with glucose and TG/HDL-C replaced with
prevalent diabetes and a total cholesterol to HDL-C ratio,
respectively. The pattern of results was the same. Prevalent
CVD was a dichotomous variable (yes=1, no=0); this
variable included a history of any of the following:
coronary artery disease, myocardial infarction, congestive
heart failure, transient ischemic attack, or angina pectoris.
These variables were assessed by self report, followed by a
medical history review (with permission). High sensitivity
CRP was assessed from plasma using a latex particle
enhanced turbidimetric immunoassay technique [38]. Five
blood pressure measurements were obtained with subjects
in each of the sitting, recumbent, and standing positions and
averaged for SBP and diastolic blood pressure (DBP).
Depressed mood was defined as a score greater than or
equal to 16 on the CES-D because the distribution of scores
is skewed and we were interested in adjusting for a
clinically accepted level for depressed mood [39]. When
analyses (results not presented) were also done with CES-D
as a continuous variable, no changes in the pattern of
significant results were observed.
Average hours per week spent on leisure time physical
activity was measured using the physical activity question-
naire from the Nurses’ Health Study [17]. This questionnaire
is reported to be a valid measure of long-term physical
activity levels [40]. Participants were asked, “during the past
year, what was your average time per week spent at each of
the following recreational activities?” Activities included
walking or hiking outdoors; jogging (slower than 10 min/
mile); running (10 min/mile or faster); bicycling; calisthen-
ics, aerobics or exercise machine use; tennis, squash, or
racquetball; lap swimming; and other aerobic recreation. The
range of possible values for each activity was 0 to 11 h. In
addition, participants were asked, “What is your usual
walking pace outdoors?” Possible responses to this question
were: easy, casual (less than 2 mph); normal, average (2–2.9
mph); brisk pace (3–3.9 mph); very brisk or striding (4 mph
or faster); and unable to walk. A MET value for each activity
was assigned using the compendium of physical activities
developed by Ainsworth et al. [41] and values used
previously by the Nurses’ Health Study investigators [17,
40]. The MET values for each activity were multiplied by the
number of hours spent at each activity to obtain MET-hours
per week for each activity. The total MET-hours per week
spent at leisure time physical activity was obtained by
summing the MET-hours for the individual activities.
Statistical Methods
Pearson product moment coefficients (r) were calculated
among WC, WHR, PA, and the cognitive outcome variables.
Distributions for hs-CRP and physical activity were skewed
and were normalized with a natural log transformation. In
separate sets of multivariate regression analyses, relations
between these independent variables and cognition were
adjusted in a sequential manner for the following covariate
sets: (1) a Basic covariate set including age, education, gender,
and number of prior exams; (2) a risk factor and CVD covariate
set (Basic + RF + CVD) including the Basic covariate set and
smoking, alcohol consumption, TG/HDL-C, prevalent CVD,
SBP, depressed mood, glucose, and CRP; (3) a Physical
Activity covariate set including the Basic + RF + CVD
covariates and physical activity. Two tailed tests of significance
(α=.05) were employed.
Results
Sample Characteristics
After exclusions, the sample consisted of 917 individuals
(59% women), aged 23–98 years. The demographics and
health characteristics of the sample are described in Table 2.
Mean values for waist circumference are comparable to
overall national averages and averages for men and women
separately [42].
Preliminary Analyses
Zero-order Correlations
Correlations among the central adiposity variables, phys-
ical activity, and cognitive outcome variables are given in
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Table 3. Waist circumference, waist/hip ratio, and physical
activity levels were significantly related to all cognitive
outcome variables. These relations were similar in strength
for all predictor variables.
Test of Interactions
Previous investigations have observed interactions between
central adiposity measures and blood pressure or hyperten-
sion [13, 14]. All tests of interactions between central
adiposity measures and blood pressure (or hypertension)
were nonsignificant for all cognitive outcome measures:
WC × SBP (ps>.11), WHR × SBP (ps>.52), WC × DBP
(ps>.28), WHR × DBP (ps>.59), WC × Hypertension
(ps>.23), WHR × Hypertension (ps>.27). When the
gender-specific waist/hip ratio cut-points (men, high
≥0.99, women, high ≥0.84) used by Wolf et al. [14] were
employed in a reanalysis, a significant WHR × Hyperten-
sion interaction was observed for Similarities (p<.01).
Participants with a high WHR and hypertension performed
more poorly than participants with a high WHR without
hypertension. The categorical WHR × Hypertension inter-
action was nonsignificant for all other cognitive outcome
measures (ps>.10). There were no significant interactions
of the predictors (WC or WHR) with age, gender, or
physical activity (ps>.05).
Basic Model
Regression coefficients (β), their respective 95% confi-
dence intervals (95% CI), and p-values for multiple
regression analyses relating WC to cognitive performance
are reported in Table 4. Because 1 cm of WC is a small
unit, regression coefficients were multiplied by 10 in order
to report cognitive performance levels in relation to 10 cm
increments in WC. Table 4 describes the magnitude of the
associations between 10 cm increases in WC and cognitive
performance expressed in units of SD (z scores). For
example, a 10-cm increment in waist circumference in the
Basic model was associated with a 0.07 SD decrement in
the Global Composite. Stated differently, a person with a
waist circumference 1.5 SD above the mean would perform
at a level 0.10 SD lower than a person with the mean waist
circumference. In the Basic Model, WC showed inverse
associations with all cognitive outcome measures, with the
Table 3 Zero-order correlations between waist circumference (cm),
waist/hip ratio, physical activity (ln MET·h·week−1), and cognitive
measures
Physical activity or central adiposity measure
Cognitive
outcome
Waist
circumference
Waist/hip
ratio
Physical
activity
Global composite r −.13*** −.21*** .19***
Verbal memory r −.09** −.16*** .11***
Visual–spatial organization r −.08* −.15*** .17***
Scanning and tracking r −.13*** −.22*** .18***
Working memory r −.11*** −.15*** .13***
Similarities r −.15*** −.08* .18***
MMSE r −.10** −.09* .09**
Waist circumference r – .70*** −.19***
Waist/hip ratio r .70*** − −.12***
r Zero-order correlation
*p<.05, **p<.01, ***p<.001
Table 2 Demographic information and health characteristics (n=917)
Variable Mean (SD)
or percent
Range
Age, mean (SD), years 62.0 (12.8) 23–98
Education, mean (SD), years 14.6 (2.7) 4–20
Women, No. (%) 541 (59.0)
Number of prior exams,
mean (SD)
1.5 (1.1) 1–5
Waist circumference (cm), mean (SD)
Overall 95.5 (15.1) 61–199
Men 102.3 (13.2) 74–186
Women 90.7 (14.5) 61–199
Waist/hip ratio, mean (SD)
Overall 0.880 (.089) 0.646–1.202
Men 0.945 (.061) 0.766–1.121
Women 0.834 (.077) 0.646–1.202
Alcohol, oz/week, mean (SD)
Drinkers only 3.0 (3.6) 0.4–33.6
Full sample 1.5 (3.0) 0–33.6
Cigarettes per week, mean (SD)
Smokers only 100.3 (74.2) 1–441
Full sample 9.4 (37.0) 0–441
Triglycerides (TG),
mmol/l, mean (SD)
1.6 (1.3) 0.3–11.3
HDL-C, mmol/l, mean (SD) 1.4 (.4) 0.4–2.6
TG/HDL ratio, mean (SD) 1.4 (1.4) 0.1–15.6
Glucose, mg/dl, mean (SD) 99.4 (29.0) 47–372
C-reactive protein, mg/l, mean (SD) 4.1 (4.6) 0.4–46.5
Systolic blood pressure,
mm Hg, mean (SD)
131.5 (21.5) 82–226
Diastolic blood pressure,
mm Hg, mean (SD)
70.8 (10.0) 45–128
Physical activity, MET-hours/week,
mean (SD)
20.5 (27.2) 0.0–216.5
Elevated waist circumferencea, No. (%) 469 (48.2)
Depressed mood, No. (%) 94 (10.3)
Smoker, No. (%) 86 (9.4)
CVD, No. (%) 141 (15.4)
Hypertensive, No. (%) 576 (62.8)
Diabetic, No. (%) 117 (12.8)
a Based on gender-specific cut points from Grundy et al. (4)
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exception of the Verbal Memory Composite. Similar rela-
tions were observed between WHR and cognitive perfor-
mance (Table 5); however, waist/hip ratio was not related to
performance on the Similarities test or the MMSE.
Basic + RF + CVD Model
When the Basic + RF + CVD covariate set was employed,
results for WC were attenuated, but significant associations
remained for the Global Composite, the Scanning and
Tracking Composite, and Similarities (Table 4). In a
slightly different pattern of results, WHR was related to
performance on the Global Composite, the Visual–Spatial
Organization Composite, and the Working Memory Com-
posite (Table 5).
Relation Between Physical Activity and Cognition
Results for the association between physical activity and
cognitive outcome variables are shown in Table 6. In
the Basic + RF + CVD covariate set with WC, physical
activity was related to all cognitive outcome measures
except the MMSE and the Verbal Memory (p>.06) and
Working Memory composites (p>.07). When WHR was
substituted for WC in this model, the pattern of results was
the same.
Basic + RF + CVD + PA Model
The addition of physical activity to the Basic + RF + CVD
model resulted in attenuation of the magnitude of the
regression coefficients for waist circumference (Table 4). In
fact, the only significant relationship observed between WC
and cognitive function with Physical Activity added to the
model was for Similarities. With adjustment for the Basic +
RF + CVD + PA covariate set, WHR was not significantly
related to any cognitive outcomes (Table 5).
Discussion
Measures of central adiposity were related to multiple
domains of cognitive functioning. With statistical control
for age, education, gender, and number of prior exams,
waist circumference and waist/hip ratio were inversely
related to the Global, Visual–Spatial Organization, Scan-
ning and Tracking, and Working Memory composites.
Waist circumference was also inversely related to the
Similarities test and the MMSE. With adjustment for
components of the metabolic syndrome and related CVD
risk factors, the associations between WC and cognitive
function were slightly attenuated, but remained significant
for the Global Composite, Scanning and Tracking Com-
Table 4 Regression coefficients (β) and 95% confidence intervals (95% CI) expressing the relationship between waist circumference (10 cm
increments) and cognitive outcome variables (z-scores)
Covariate set
Cognitive outcome Basica Basic + RFb + CVD Basic + RF+ CVD + PAc
Global composite β −0.0655*** −0.0543* −0.0405
95% CI (−0.1036, −0.0274) (−0.0975, −0.0110) (−0.0849, 0.0039)
Verbal memory β −0.0162 −0.0045 0.0016
95% CI (−0.0589, 0.0264) (−0.0526, 0.0436) (−0.0477, 0.0509)
Visual–spatial organization β −0.0504* −0.0405 −0.0276
95% CI (−0.0899, −0.0109) (−0.0849, 0.0040) (−0.0732, 0.0180)
Scanning and tracking β −0.0534** −0.0487* −0.0349
95% CI (−0.0905, −0.0164) (−0.0910, −0.0065) (−0.0782, 0.0084)
Working memory β −0.0541* −0.0407 −0.0282
95% CI (−0.0988, −0.0095) (−0.0911, 0.0097) (−0.0799, 0.0236)
Similarities β −0.0791*** −0.0682** −0.0615*
95% CI (−0.1207, −0.0374) (−0.1155, −0.0209) (−0.1100, −0.0130)
MMSE β −0.0437* −0.0186 −0.0188
95% CI (−0.0873, −0.0000) (−0.0669, 0.0296) (−0.0684, 0.0308)
*p<.05, **p<.01, ***p<.001
a Basic covariate set = age, education, gender, number of prior exams
b Basic + RF + CVD covariate set = age, education, gender, number of prior exams, smoking, alcohol consumption, triglycerides/high
density lipoprotein cholesterol ratio, prevalent cardiovascular disease, systolic blood pressure, depressed mood, glucose, high sensitivity C-
reactive protein
c Basic + RF + CVD + PA covariate set = age, education, gender, number of prior exams, smoking, alcohol consumption, triglycerides/high
density lipoprotein cholesterol ratio, prevalent cardiovascular disease, systolic blood pressure, depressed mood, glucose, high sensitivity C-
reactive protein, physical activity
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posite, and Similarities. The associations between WHR
and cognitive function were also attenuated in this model,
but significant associations remained for the Global,
Visual–Spatial Organization, and Working Memory com-
posites. Generally, these findings are similar to those of
previous studies investigating the relationship between
central adiposity and cognition [13, 14], BMI and cognition
[7], and BMI-defined obesity and cognition [5].
Previous studies investigating the relationship between
central adiposity and cognitive function have found that
measures of central adiposity are inversely related to cogni-
tive function, but only for hypertensive individuals [13, 14].
In the study by Waldstein and Katzel [13], this interaction
was found only for tests that are not included in the Maine–
Syracuse battery and was not significant for tests which are
included in the present battery, suggesting that this effect
Table 6 Regression coefficients
(β) and 95% confidence intervals
(95% CI) expressing the rela-
tionship between physical
activity (ln MET·hours·week−1)
and cognitive outcome variables
(z-scores) in the Basic + RF +
CVD covariate set
Basic + RF + CVD covariate
set = [obesity covariate], age,
education, gender, number of
prior exams, smoking, alcohol
consumption, triglycerides/high
density lipoprotein cholesterol
ratio, prevalent cardiovascular
disease, systolic blood pressure,
depressed mood, glucose, high
sensitivity C-reactive protein.
*p<.05, **p<.01, ***p<.001
Obesity covariate
Cognitive outcome Waist
circumference
Waist/hip ratio
Global composite β 0.0577** 0.0601**
95% CI (0.0147, 0.1007) (0.0171, 0.1030)
Verbal memory β 0.0439 0.0447
95% CI (−0.0042, 0.0920) (−0.0034, 0.0929)
Visual–spatial
organization
β 0.0493* 0.0482*
95% CI (0.0049, 0.0937) (0.0038, 0.0925)
Scanning and
tracking
β 0.0654** 0.0706***
95% CI (0.0236, 0.1072) (0.0288, 0.1124)
Working memory β 0.0455 0.0437
95% CI (−0.0050, 0.0960) (−0.0068, 0.0942)
Similarities β 0.0529* 0.0615*
95% CI (0.0056, 0.1002) (0.0140, 0.1090)
MMSE β −0.0108 −0.0093
95% CI (−0.0590, 0.0374) (−0.0575, 0.0389)
Table 5 Regression coefficients (β) and 95% confidence intervals (95% CI) expressing the relationship between waist/hip ratio and cognitive
outcome variables (z-scores)
Covariate set
Cognitive outcome Basica Basic + RFb + CVD Basic + RF + CVD + PAc
Global composite β −1.2697*** −0.8187* −0.5237
95% CI (−2.0292, −0.5101) (−1.6325, −0.0048) (−1.3587, 0.3041)
Verbal memory β −0.2527 0.1832 0.3189
95% CI (−1.1106, 0.6052) (−0.7321, 1.0985) (−0.6161, 1.2539)
Visual–spatial organization β −1.3625*** −0.9094* −0.6840
95% CI (−2.1525, −0.5725) (−1.7515, −0.0673) (−1.5451, 0.1771)
Scanning and tracking β −0.7461* −0.3856 −0.0522
95% CI (−1.4858, −0.0064) (−1.1809, 0.4097) (−0.8627, 0.7584)
Working memory β −1.3172** −0.9938* −0.7432
95% CI (−2.2134, −0.4210) (−1.9521, −0.0355) (−1.7245, 0.2382)
Similarities β −0.6602 −0.3586 −0.1192
95% CI (−1.5037, 0.1834) (−1.2628, 0.5455) (1.0425, 0.8041)
MMSE β −0.7237 −0.2117 −0.1760
95% CI (−1.5977, 0.1504) (−1.1259, 0.7026) (−1.1130, 0.7610)
*p<.05, **p<.01, ***p<.001
a Basic covariate set = age, education, gender, number of prior exams
b Basic + RF + CVD covariate set = age, education, gender, number of prior exams, smoking, alcohol consumption, triglycerides/high
density lipoprotein cholesterol ratio, prevalent cardiovascular disease, systolic blood pressure, depressed mood, glucose, high sensitivity C-
reactive protein
c Basic + RF + CVD + PA covariate set = age, education, gender, number of prior exams, smoking, alcohol consumption, triglycerides/high
density lipoprotein cholesterol ratio, prevalent cardiovascular disease, systolic blood pressure, depressed mood, glucose, high sensitivity C-
reactive protein, physical activity
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may be specific to cognitive domains not measured in the
current study. Wolf et al. [14] found that elevated waist/hip
ratio predicted lowered cognitive function only in the
presence of hypertension, but this study did not include
adjustment for cardiovascular risk factors. Therefore, it is
uncertain whether this lowered performance is due to a
synergistic effect of elevated central adiposity and hyper-
tension or to other closely related cardiovascular risk factors,
such as diabetes or increased systemic inflammation.
Previous studies have shown self-reported physical
activity [43] and objective measures of cardiorespiratory
fitness [44] to be robust predictors of cognitive function
across multiple domains [16], with the largest effects
observed for measures of executive function. However,
few studies investigating the relationship between obesity
and cognitive function have included a measure of physical
activity or physical fitness [7, 13]. Thus, one major purpose
of our study was to determine if physical activity level
modified the relationship between measures of central
adiposity and cognitive performance. Physical activity was
positively and significantly related to cognitive function,
even after adjustment for CVD risk factors, CVD, and
central adiposity. With adjustment for physical activity,
however, waist circumference was related only to the
Similarities test, and waist/hip ratio was not significantly
related to any outcome measures. One possibility is that this
finding was due to chance because it represents one
statistically significant finding within the context of
multiple analyses with adjustment for physical activity.
Although cardiovascular disease events and risk factors
may partially mediate associations between central adipos-
ity and cognition, our study and others [13] have shown
that relations between central adiposity and cognition are
sustained regardless of statistical adjustment for cardiovas-
cular risk factors and events. Clearly no study to date has
adjusted for all possible risk factors and cardiovascular
events. On the other hand, there are other mechanisms that
might possibly explain the relation between central adipos-
ity and cognition.
Central adiposity has been linked to an increase in
prevalence of white matter hyperintensities in the brain [45]
and to emerging risk factors for cardiovascular disease such
as elevated systemic inflammation [46]. It is not highly
likely that systemic inflammation provides an explanation
in the present study because, unlike previous studies, we
adjusted for C-reactive protein as a possible confounder.
There are several possible mechanisms which may
explain the relationship between physical activity levels
and cognitive function, and why adjustment for physical
activity attenuates results for adiposity variables. One possi-
bility is that this phenomenon is simply due to collinearity
between central adiposity and activity level. However,
correlational analyses do not support this interpretation.
It is not unreasonable to hypothesize that increased
levels of physical activity result in weight loss, thereby
decreasing the amount of adipose tissue. Although one of
the likely consequences of physical activity is weight loss,
beneficial effects of physical activity on cardiovascular
disease risk factors are also observed in the absence of
profound weight loss [47]. The current study suggests that
the association between physical activity and cognitive
function may be only partially mediated through adipose
tissue. However, there are several possible alternative
explanations for the association between physical activity
and cognitive function. Physical activity has been shown to
increase serotonin and dopamine levels [48], as well as
increasing insulin sensitivity [49]. These compounds have
all been shown to be positively correlated with cognition
[50–52]. Physical activity also has beneficial effects on the
vascular system, including reduction of atherosclerotic
plaque accumulation [53], decreased blood pressure [54],
and subsequent reduction of cardiovascular disease risk
[55]. Investigations have also found increased neurogenesis
as a result of exercise in the rat [56, 57].
The cross-sectional design is a limitation of the current
study. Participants with higher levels of cognitive function
may be more likely to engage in health-promoting
behaviors. Another limitation of the current study was the
fact that physical activity levels were measured by self-
report, which may have been affected by erroneous recall.
Also, retrospectively estimating physical activity levels
requires cognitive skills assessed by some of the outcome
measures. However, physical activity and cognition have
been shown to be positively related cross-sectionally [15],
prospectively [58], and longitudinally [17]. Thus, the fact
that physical activity and cognition are positively correlated
in the present study is unlikely to be simply the result of
erroneous recall. Further, a greater extent of erroneous
recall among poorer cognitive performers would increase
the variability in the physical activity measure. This
increased variability would result in an underestimation of
the magnitude of the association between physical activity
and cognitive function. Lastly, this sample was composed
of relatively high-functioning subjects, so recall of past
physical activity levels and responding to physical activity
questions probably make minimal demands on their
intellect. However, it is important to consider these
possibilities in future studies using longitudinal assessments
of cognition and physical activity.
Strengths of the current study include a relatively large
community-based sample, objective data on risk factors
for CVD and CVD events, and a validated measure of
activity level.
While CVD risk factors have been adjusted in previous
studies of obesity and waist/hip ratio, to our knowledge, no
studies have simultaneously adjusted for activity level. In
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summary, measures of central adiposity were related to
multiple measures of cognitive function. This association
was significantly attenuated with statistical adjustment for
leisure-time physical activity levels. Thus it is important to
include a measure of physical activity or cardiorespiratory
fitness in addition to CVD risk factors when investigating
the relationship between obesity and cognitive function.
Aside from central adiposity, our study reinforces the recent
recommendations for minimal levels of physical activity
[59]. Further studies are needed to investigate the vascular,
endocrine, and neurochemical mechanisms explaining the
association between physical activity and cognitive func-
tion, and the extent to which these mechanisms are
independent of obesity.
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